Ken Griffin's position in LB PharmaceuticalsCommon Stock is currently worth $12.5M. That's 0.01% of their equity portfolio (1358th largest holding). The investor owns 1.45% of the outstanding LB PharmaceuticalsCommon Stock stock. The first LB PharmaceuticalsCommon Stock trade was made in Q3 2025. Since then Ken Griffin bought shares one more times and sold shares on one occasions. The stake costed the investor $9.5M, netting the investor a gain of 32% so far.